Arthritis drug, Vioxx, a cox-2 inhibitor made by Merck & Co. Inc., has been cleared to return to market by Canadian health officials, nearly a year after it was pulled off the shelves amid fears of increasing cardiovascular problems.
Comments (0)
Please sign in to leave a comment.
No comments yet. Be the first to comment!